BIOTEC PHARMACON ASA NK 1

Balance sheet

Assets 78,000,000  EUR 91,000,000  EUR 100,000,000  EUR 42,000,000  EUR
Current Assets 78,000,000  EUR 91,000,000  EUR 100,000,000  EUR 42,000,000  EUR
Cash And Cash Equivalents 58,000,000  EUR 78,000,000  EUR 88,000,000  EUR 34,000,000  EUR
Net Receivables 17,000,000  EUR 10,000,000  EUR 8,000,000  EUR 6,000,000  EUR
Inventory 3,000,000  EUR 3,000,000  EUR 4,000,000  EUR 2,000,000  EUR
Liabilities 189,000,000  EUR 188,000,000  EUR 183,000,000  EUR 105,000,000  EUR
Equity 177,000,000  EUR 177,000,000  EUR 173,000,000  EUR 95,000,000  EUR
Common Stock 177,000,000  EUR 177,000,000  EUR 173,000,000  EUR 95,000,000  EUR
Current Liabilities 7,000,000  EUR 6,000,000  EUR 5,000,000  EUR 5,000,000  EUR
Accounts Payable 7,000,000  EUR 6,000,000  EUR 5,000,000  EUR 5,000,000  EUR
Deferred Long Term Liability Charges 5,000,000  EUR 5,000,000  EUR 5,000,000  EUR 5,000,000  EUR

Key figures

On 31/12/16 the equity of company BIOTEC PHARMACON ASA NK 1 was 177,000,000 EUR.  As its assets have been 78,000,000 EUR the equity ratio is 226.92 %.  As the equity ratio is very high, the risk of selective default is lower than average. An investment in bonds of this company can be recommended, though first a deeper analysis of the current financial situation of BIOTEC PHARMACON ASA NK 1 should take place.

NO0010014632: ARCTICZYMES TECH ASA NK 1
The book value per share of ARCTICZYMES TECH ASA NK 1 (ISIN: NO0010014632) is 0. Current market price is 407.0000 Euro. As the current market price is higher than the book value per share, this financial instrument might not be a promising investment. Please check whether there are other factors like goodwill that justify this valuation.

Ticker Symbols

B4V.F

B4V.SG

BIOTEC.OL

BIOTECO.ST